ArticleNeuroImage. Clinical2026
The specific linear or curved boundaries between WHO grade II-III insular gliomas and the basal ganglia indicate distinct biological features, survival outcomes, and surgical strategies: evidence from 330 cases.
Article in NeuroImage. Clinical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWHO grade II-III insular glioma (InG) can displace the basal ganglia, resulting in distinct linear or curved boundary shapes. This study retrospectively explored this morphological distinction and its clinical relevance.
methodsMRI and clinical data were collected from Beijing Tiantan Hospital over the past 20 years. The boundary shape on the FLAIR sequence was characterized using the fractal dimension (FD) and curved parameters. Statistical analyses included the χ
resultsA total of 330 patients were included. Based on the FD, patients were classified into linear ('L'; 49%) and curved ('C'; 51%) subgroups. Compared with the L subgroup, the C subgroup exhibited more favorable biological features and progression-free survival (PFS) (p < 0.001). Using routine pathological variables, regression models were constructed to identify crucial factors in different subgroups and perform disease stratification for Statistical explanation. Internal validation supported model stability. With regard to surgical responses, although the rate of gross total resection (GTR) was higher in the L subgroup, the PFS was not increased, whereas that of the C subgroup demonstrated an increase (p < 0.001).
conclusionsThe boundary shape between WHO grade II-III InG and the basal ganglia may reflect differences in biological features, survival outcomes, and surgical responses. Thus, the boundary shape should be considered in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.